• 1
    Handler J. Hydralazine-induced lupus erythematosis. Clin Exp Pharmacol Physiol. 2009;36:1839842.
  • 2
    Xu B, Thornton C, Tooher J, et al. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro. Crit Care Med. 2009;36:839842.
  • 3
    Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002;30:S58S63.
  • 4
    Ling GS, Cook HT, Botto M, et al. An essential pretective tole of IL-10 in the immunological mechanism underlying resistance vs. susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology (Oxford). 2011;50:17731784.
  • 5
    Blenman KR, Duan B, Xu Z, et al. IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest. 2006;86:11361148.
  • 6
    Yin Z, Bahtiyar G, Zhang N, et al. IL-10 regulates murine lupus. J Immunol. 2002;169:21482155.